Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • Court Restrains...

Court Restrains Medreich from Using Jubilant's Losartan, Amlodipine, Citalopram Dossiers

Farhat NasimWritten by Farhat Nasim Published On 2025-03-07T18:44:01+05:30  |  Updated On 7 March 2025 6:44 PM IST
Gujarat HC major relief to student, directs NTA to release her NEET UG result within 15 days
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

Noida: In relief to Jubilant Generics Ltd, the Commercial Court No. II, Gautam Buddh Nagar, has granted a temporary injunction against Medreich Limited and three other defendants in a high-stakes intellectual property dispute concerning pharmaceutical product dossiers. The dispute centers around three key drugs, Losartan, Amlodipine, and Citalopram which Jubilant Generics alleges were unlawfully accessed and used for manufacturing in India in violation of its exclusive licensing agreements.

The order, delivered by Judge Kunal Vepa on February 25, 2025, restrains the defendants from using, reproducing, or sharing the copyright-protected product dossiers of Jubilant Generics and from manufacturing, distributing, or exporting the disputed pharmaceutical products.

The legal battle began when Jubilant Generics Ltd filed an original suit for permanent injunction on August 23, 2024, alleging that Medreich Limited and its co-defendants had illegally acquired and used confidential product dossiers belonging to the plaintiff. Jubilant argued that the unauthorized use of these dossiers amounted to copyright infringement, misappropriation of trade secrets, and breach of confidentiality agreements.

According to the plaintiff, the product dossiers in question pertained to three pharmaceutical formulations—Losartan, Amlodipine, and Citalopram—which had been developed by Jubilant Generics and licensed exclusively to Jamp Pharma Corporation, Canada, under a confidentiality and non-disclosure agreement (NDA) signed in 2010. The licensing agreement permitted Jamp Pharma to manufacture, distribute, and sell these drugs exclusively in Canada.

However, Jubilant alleged that Jamp Pharma unlawfully shared the product dossiers with Medreich Limited and three other Indian pharmaceutical companies, which then manufactured these drugs in India, in violation of the intellectual property rights of Jubilant Generics. The plaintiff contended that this constituted a breach of Section 51 of the Copyright Act, 1957.

After reviewing extensive arguments and documentation, the Commercial Court ruled in favor of Jubilant Generics, concluding that the plaintiff had established a prima facie case of copyright infringement. The court noted that Medreich Limited and the other defendants were not parties to the original licensing agreements and had no legal right to access or use Jubilant's intellectual property. In its ruling, the court observed;

"Jamp Pharma was duty-bound to purchase the said products from the plaintiff for the Canadian market. However, the defendants, who were never privy to the original agreements, have unlawfully gained access to and used the product dossiers for manufacturing in India, which is a blatant infringement of the plaintiff’s copyright."

Further emphasizing the importance of territorial restrictions, the court ruled;

"Jamp Pharma’s rights under the agreement were limited to Canada. The use of the plaintiff’s product dossiers by entities outside Canada for manufacturing, as admitted by defendant No. 4, is a clear breach of contract and intellectual property rights."

Additionally, the court rejected the defendants' claim that the agreements had expired and that Jamp Pharma had the right to share the product dossiers, stating;

"While the arbitration proceedings between Jubilant and Jamp Pharma are ongoing in Canada, the present suit concerns third-party defendants who were not part of the original agreements. Therefore, this matter is within the jurisdiction of this court."

The court further noted that allowing the defendants to continue manufacturing the drugs in India would cause irreparable harm to Jubilant Generics, stating;

"The plaintiff’s right to protect their intellectual property shall prevail over the commercial interest of the defendants. The unauthorized use of the plaintiff’s product dossiers by the defendants has led to a loss of unique property, which cannot be compensated in monetary terms."

Based on its findings, the Commercial Court issued a fresh temporary injunction, restraining the defendants from using, reproducing, or distributing the disputed product dossiers. It also barred them from manufacturing, distributing, or exporting the pharmaceutical products in question and sharing the confidential product dossiers with any third party. It held;

"In view of the above discussion, the answering defendants are hereby restrained from reproducing or using in any manner the copyrights protected product dossiers of the plaintiff in relation to the said products, and also for manufacturing, distributing and exporting the said products to any entity. The defendants are also restrained from sharing with any third party, or using directly or indirectly the plaintiff confidential information including the product dossiers in whole or in part for the said products."

The court also ordered that the temporary injunction will remain in place until the final disposal of the case. The next hearing on related procedural matters is scheduled for April 9, 2025.

To view the original order, click on the link below:

https://medicaldialogues.in/pdf_upload/k8s0bu2ncd546liji4ve8jhmvs-277520.pdf
jubilant genericsmedreich limitedpharmaceutical ip disputecommercial court noidadrug dossier infringementlosartanamlodipinecitaloprampharma licensingjamp pharmacopyright violationpharma newscopyrightInfringement
Farhat Nasim
Farhat Nasim

    Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    View All

    Journal Club Today

    Study Reveals Why Your Immune System Works Better in Daylight

    Study Reveals Why Your Immune System Works Better in Daylight

    View All

    Health News Today

    Health Bulletin 29/May/2025

    Health Bulletin 29/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok